GRDN vs REGN · rev $377.4M vs P/E 14, rev $14.34B
Guardian Pharmacy Services, Inc. (GRDN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Guardian Pharmacy Services, Inc. (GRDN) is a medical care facilities company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported GRDN revenue for 2025-09-30 was $377.4M. Net income was $9.6M. Revenue was up 9.6% from 2025-06-30 to 2025-09-30. GRDN currently screens at market cap $1.25B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
GRDN currently screens at market cap $1.25B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the GRDN and REGN stock pages for the full models.
Not investment advice.